2m 2m 2m 2m 2m 2m 2m
ARVINAS (ARVN)
NASDAQ
$9.21-$0.15 (-1.66%)
Price as of Aug 21, 2026 7:30 PM EDT- $612.3MMarket Cap
- 27.94%1-Year Change
- BiotechnologyIndustry
ARVINAS (ARVN)
$9.21-$0.15 (-1.66%)
ARVN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $9.37 | ||
Change | +$0.34 (+3.77%) | ||
Open | $9.02 | ||
High | $9.39 | ||
Low | $9.00 | ||
Previous Close | $9.03 | ||
Volume | 951,752 | ||
30-Day Average Volume | 878,876 | ||
1-Week Change | 4.40% | ||
1-Month Change | 13.38% | ||
1-Year Change | 27.94% | ||
3-Year Change | -64.87% | ||
5-Year Change | -89.09% | ||
Fundamentals | |||
Shares Outstanding | 65.4M | ||
Total Assets | $675.1M | ||
Market Cap | $612.3M | ||
Enterprise Value | $518.5M | ||
Period: QTR TTM FY | |||
Revenue | $249.7M | ||
Net Income | $169.4M | ||
Free Cash Flow | -$48.5M | ||
EBIT | $169.6M | ||
EBITDA | $170.3M | ||
Net Working Capital | $569.7M | ||
EPS | $2.58 | ||
Enterprise Value/EBITDA | 3 | ||
Enterprise Value/Revenue | 2 | ||
P/B | 1 | ||
P/E | 4 | ||
PEG | 0 | ||
Price/Free Cash Flow | -13 | ||
Price/Operating Cash Flow | -13 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue